Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including The American Journal of Accountable Care®, Evidence-Based Oncology™, and The Center for Biosimilars®. She has been working on AJMC® since 2014 and has been with AJMC®’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
Hospitals' Uncompensated Care Costs Will Decline $5.7 Billion
The Affordable Care Act will save hospitals a projected $5.7 billion in uncompensated care this year, according to a report released by HHS. Roughly three-quarters of those savings are coming from Medicaid expansion states.
Eight Strategies to Drive Patient Engagement and Improve Healthcare Delivery
Patient experience and satisfaction is becoming an increasingly important aspect of providing healthcare, and a new roadmap outlines opportunities and key strategies to include patients and families in healthcare delivery.
Marketplaces Will Have 25% More Insurers in 2015
The health insurance Marketplace will have 77 new insurers offering coverage in 2015, according to a report released by HHS. Overall, there will be a net 25% increase in the number of insurers that consumers will be able to choose from.
Consumers Find ACA Insurance Plans Affordable
Although a majority of adults with health insurance purchased through the Affordable Care Act's marketplace said they find it easy to afford the care they need, the number of people still enrolled has dipped to 7.3 million, according to recent numbers.
GAO Report: Healthcare.gov Needs to Address Security Weaknesses
After examining the security and privacy of the Healthcare.gov website and its supporting systems at CMS, the Government Accountability Office published a report with 6 security management and 22 technical security recommendations.
Tens of Thousands at Risk of Losing ACA Insurance Coverage
The federal government will terminate health insurance coverage under the Affordable Care Act for 115,000 individuals who failed to prove they were United States citizens or legal immigrants. Furthermore, another 363,000 people could lose their financial aid because of income reporting discrepancies.
HHS Awards $295 Million in Funding to Expand Primary Care Services
More than 1,000 health centers in every US state and territory will receive Affordable Care Act funds to expand their primary care services, according to an announcement from Health and Human Services' Secretary Sylvia M. Burwell.
Making Treatment Decisions When There Is an Abundance of Options
Despite the benefit of having more choices than ever before to treat patients with multiple sclerosis, the abundance of options has led to more complexity, according to speakers at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.
The Power of Treating Patients as Partners in MS Clinical Research
As a medium, the Internet neither helps nor harms in multiple sclerosis care - what matters is how clinicians and patients engage in that medium, according to Paul Wicks, PhD, vice president of innovation at PatientsLikeMe.
Improving Patient-Clinician Communication and Treatment Adherence
Although there have been significant advances in multiple sclerosis management, patient preferences need to be taken into account before choosing treatment, according to speakers at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.
Engaging Patients in Their Own Treatment Decisions
Patients with multiple sclerosis want to be actively engaged in their treatment decisions, which will help their long-term health and medication adherence, according to speakers at the 2014 ACTRIMS-ECTRIMS Joint Meeting in Boston, Massachusetts.
Heterogeneity of MS Makes New Disease Biomarker Discovery Difficult
The treatment landscape for multiple sclerosis continues to get more complex month to month, which makes biomarker discovery increasingly important for treating the disease, said Suhayl Dhib-Jalbut, MD, professor at the Rutgers University Robert Wood Johnson Medical School, during his session at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston, Massachusetts.
PML is Treatable in MS, but Long-Term Function Can Remain Affected
Although the survival rate of natalizumab-associated progressive multifocal leukoencephalopathy (PML) is better than PML in HIV patients, long-term they may need some assistance and care, Ralf Gold, Ruhr University Bochum in Germany, said at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston, Massachusetts.
Using Advanced Imaging Techniques to Better Understand MS Progression
Advanced imaging techniques are becoming necessary to further understanding of the progression of multiple sclerosis, according to presenters at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston, Massachusetts, from September 10-13.
Collaborative Decision Making Tops Efficacy for MS Patients
When choosing treatment for a patient, whether he or she has a clinically isolated syndrome or clinically definite multiple sclerosis, providers need to establish a collaborative relationship, according to speakers at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston, Massachusetts.